Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
DAWN —
DAY ONE BIOPHARMACEUTICALS I
CUSIP: 23954D109 · Held by 2 superinvestors · Combined value: $28,049,444
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $15,886,061 | 1,704,513 | ADD | +1,041,300 |
| 2 | Jim Simons | 0.0% | $12,163,383 | 1,305,084 | ADD | +399,608 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +399,608 | +44.1% |
| Ken Griffin | ADD | +1,041,300 | +157.0% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -95,064 | -9.5% |
| Ken Griffin | REDUCE | -83,531 | -11.2% |
Who Owns DAWN? Superinvestor Holdings
DAY ONE BIOPHARMACEUTICALS I is held by 2 tracked superinvestors, with a combined position value of $28 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.